Abatacept (ABT) is a unique biological DMARD (bDMARD) that inhibits T lymphocyte costimulation and is therapeutically effective against moderate-to-severe RA, especially ACPA-positive RA [9]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.